From Casetext: Smarter Legal Research

BCBSM, Inc. v. Vyera Pharmaceuticals, LLC

United States District Court, Southern District of New York
Jul 26, 2021
21cv1884 (DLC) (S.D.N.Y. Jul. 26, 2021)

Opinion

21cv1884 (DLC)

07-26-2021

BCBSM, INC., d/b/a BLUE CROSS and BLUE SHIELD OF MINNESOTA, on behalf of itself and those similarly situated, Plaintiff, v. VYERA PHARMACEUTICALS, LLC, PHOENIXUS AG, MARTIN SHKRELI, and KEVIN MULLEADY, Defendants.


ORDER

DENISE COTE United States District Judge

In a letter of July 21, 2021, the plaintiff seeks deposition testimony from defendant Kevin Mulleady on the ground that Mulleady “engaged in new conduct that calls into question Defendants' core arguments and testimony.” Specifically, the plaintiff refers to two news articles. Only one of the articles quotes Mulleady directly, and the quotes are not sufficiently relevant to the merits of the claims to warrant additional deposition testimony. Accordingly, it is hereby

ORDERED that the plaintiff's July 21 request for deposition testimony of Mulleady is denied.


Summaries of

BCBSM, Inc. v. Vyera Pharmaceuticals, LLC

United States District Court, Southern District of New York
Jul 26, 2021
21cv1884 (DLC) (S.D.N.Y. Jul. 26, 2021)
Case details for

BCBSM, Inc. v. Vyera Pharmaceuticals, LLC

Case Details

Full title:BCBSM, INC., d/b/a BLUE CROSS and BLUE SHIELD OF MINNESOTA, on behalf of…

Court:United States District Court, Southern District of New York

Date published: Jul 26, 2021

Citations

21cv1884 (DLC) (S.D.N.Y. Jul. 26, 2021)